Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Halliday

Showing results (231-240 of 235) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 235 results.
Neuroreport|November 27, 1998
Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's diseaseK Taddei, J B Kwok, J J Kril, et al.
Experimental Neurology|March 18, 2009
Anti-melanin antibodies are increased in sera in Parkinson's diseaseK L Double, D B Rowe, F M Carew-Jones, et al.
The British Journal of Dermatology|April 11, 2016
A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipientsA C Chen, A J Martin, R A Dalziell, et al.
Brain Communications|August 1, 2022
Utility of the Addenbrooke's Cognitive Examination III online calculator to differentiate the primary progressive aphasia variantsD Foxe, A Hu, S C Cheung, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 10, 2017
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking PalsyJ A Obeso, M Stamelou, C G Goetz, et al.
Pageof 24

Showing results (231-240 of 235) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 235 results.
Neuroreport|November 27, 1998
Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's diseaseK Taddei, J B Kwok, J J Kril, et al.
Experimental Neurology|March 18, 2009
Anti-melanin antibodies are increased in sera in Parkinson's diseaseK L Double, D B Rowe, F M Carew-Jones, et al.
The British Journal of Dermatology|April 11, 2016
A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipientsA C Chen, A J Martin, R A Dalziell, et al.
Brain Communications|August 1, 2022
Utility of the Addenbrooke's Cognitive Examination III online calculator to differentiate the primary progressive aphasia variantsD Foxe, A Hu, S C Cheung, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 10, 2017
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking PalsyJ A Obeso, M Stamelou, C G Goetz, et al.
Pageof 24